Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 5:12 pm Purchase | 13G | INVIVYD, INC. IVVD | MAVERICK CAPITAL LTD | 9,343,949 8.5% | 9,343,949 (New Position) | View |
2024-02-12 4:01 pm Purchase | 13G | INVIVYD, INC. IVVD | Deep Track Capital LP | 9,000,000 7.56% | 9,000,000 (New Position) | View |
2024-02-09 09:16 am Sale | 13G | INVIVYD, INC. IVVD | FMR LLC | 8,411,969 7.639% | -161,813 (-1.89%) | View |
2024-01-22 4:15 pm Sale | 13D | INVIVYD, INC. IVVD | Adimab LLC | 21,687,906 19.7% | -5,000,000 (-18.74%) | View |
2023-09-11 08:23 am Sale | 13G | INVIVYD, INC. IVVD | FMR LLC | 8,573,782 7.811% | -5,537,200 (-39.24%) | View |
2023-02-09 11:18 am Sale | 13G | INVIVYD, INC. IVVD | FMR LLC | 14,110,982 12.947% | -1,481,600 (-9.50%) | View |
2022-08-19 5:22 pm Purchase | 13D | INVIVYD, INC. IVVD | M28 Capital Management LP | 9,248,250 8.5% | 2,850,000 (+44.54%) | View |
2022-07-05 08:11 am Unchanged | 13D | INVIVYD, INC. IVVD | MITHRIL II LP | 11,241,580 10.2% | 0 (Unchanged) | View |
2022-06-24 5:10 pm Unchanged | 13D | INVIVYD, INC. IVVD | MITHRIL II LP | 11,241,580 10.2% | 0 (Unchanged) | View |
2022-06-24 5:07 pm Unchanged | 13D | INVIVYD, INC. IVVD | Population Health Equity Partners III L.P. | 1,201,680 1.1% | 0 (Unchanged) | View |
2022-06-24 4:54 pm Unchanged | 13D | INVIVYD, INC. IVVD | Adimab LLC | 26,687,906 24.3% | 0 (Unchanged) | View |
2022-06-24 4:47 pm Unchanged | 13D | INVIVYD, INC. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.8% | 0 (Unchanged) | View |
2022-06-24 4:15 pm Unchanged | 13D | INVIVYD, INC. IVVD | M28 Capital Management LP | 6,398,250 5.78% | 0 (Unchanged) | View |
2022-04-26 11:45 am Unchanged | 13D | INVIVYD, INC. IVVD | M28 Capital Management LP | 6,398,250 5.78% | 0 (Unchanged) | View |
2022-04-25 9:54 pm Unchanged | 13D | INVIVYD, INC. IVVD | Population Health Equity Partners III L.P. | 1,201,680 1.1% | 0 (Unchanged) | View |
2022-04-25 9:41 pm Unchanged | 13D | INVIVYD, INC. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.8% | 0 (Unchanged) | View |
2022-04-25 9:26 pm Unchanged | 13D | INVIVYD, INC. IVVD | MITHRIL II LP | 11,241,580 10.2% | 0 (Unchanged) | View |
2022-04-25 8:11 pm Unchanged | 13D | INVIVYD, INC. IVVD | Adimab LLC | 26,687,906 24.3% | 0 (Unchanged) | View |
2022-04-06 6:05 pm Purchase | 13D | INVIVYD, INC. IVVD | Population Health Equity Partners III L.P. | 1,201,680 1.1% | 1,201,680 (New Position) | View |
2022-04-01 06:00 am Purchase | 13D | INVIVYD, INC. IVVD | M28 Capital Management LP | 6,398,250 5.78% | 733,029 (+12.94%) | View |